Central venous/vascular access devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream. Venous access devices that can be implanted under the skin were introduced in 1982. They allow medications to be delivered directly into larger veins, are less likely to clot, and can be left in for long periods. The CVAD may contain one or two tubes. When a CVAD contains two tubes, it is called a double or dual lumen catheter and may also be used for injecting contrast for CT or MRI scans (depending on type of CVAD).
The global Central Vascular Access Device market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Central Vascular Access Device by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Centrally Inserted Catheters (non-tunnelled and tunnelled)
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
C. R. Bard, Inc.
Smiths Medical, Inc.
B. Braun Melsungen AG
Vygon (UK) Ltd
Ameco Medical Industries
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)